A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Seagen Inc.
Seagen Inc.
A2 Biotherapeutics Inc.
National Institutes of Health Clinical Center (CC)
Azienda Ospedaliero-Universitaria di Parma
Takeda
VM Oncology, LLC
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Actym Therapeutics, Inc.
TCR2 Therapeutics
University of Pittsburgh
Azienda USL Reggio Emilia - IRCCS
Cancer Research UK
Alliance for Clinical Trials in Oncology
BerGenBio ASA
Sheffield Teaching Hospitals NHS Foundation Trust
NGM Biopharmaceuticals, Inc
UTC Therapeutics Inc.
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
NGM Biopharmaceuticals, Inc
Massachusetts General Hospital
Quadriga Biosciences, Inc.
MacroGenics
Abramson Cancer Center at Penn Medicine
Shenzhen BinDeBio Ltd.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
NHS Greater Glasgow and Clyde
Masonic Cancer Center, University of Minnesota
Chinese PLA General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Morphotek
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Anza Therapeutics, Inc.